# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-23-013565
Filing Date
2023-04-20
Accepted
2023-04-20 07:01:56
Documents
5
Period of Report
2023-06-09

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | iron-2023-proxy-def14a.htm | DEF 14A | 1147399
2 | GRAPHIC | img140263681_0.jpg | GRAPHIC | 4569
3 | GRAPHIC | img140263681_1.jpg | GRAPHIC | 4569
4 | GRAPHIC | img140263681_2.jpg | GRAPHIC | 1241112
5 | GRAPHIC | img140263681_3.jpg | GRAPHIC | 1036707
| Complete submission text file | 0000950170-23-013565.txt |  | 4297774

Mailing Address 300 ONE KENDALL SQUARE, 3RD FLOOR CAMBRIDGE MA 02139
Business Address 300 ONE KENDALL SQUARE, 3RD FLOOR CAMBRIDGE MA 02139 (617) 401-4400
Disc Medicine, Inc. (Filer) CIK: 0001816736 (see all company filings)

EIN.: 851613057 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39438 | Film No.: 23831377
SIC: 2834 Pharmaceutical Preparations